Impairment of thioredoxin reductase activity by oxidative stress in human rheumatoid synoviocytes

References

• Pap T, Muller-Ladner U, Gay RE, Gay S. Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 2000; 2: 61–67
   Google Scholar
• Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum 1996; 39: 1781–1790
   PubMed Web of Science ®Google Scholar
• Tak PP, Zwaifler NJ, Green DR, Firestein GS. Rheumatoid arthritis and p53: How oxidative stress might alter the course of inflammatory diseases. Immunol Today 2000; 21: 78–82
   PubMedGoogle Scholar
• Mapp PI, Grootved MC, Blake DR. Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 1995; 51: 419–436
   PubMed Web of Science ®Google Scholar
• Hitchon CA, El-Gabalawy H. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004; 6: 265–278
   PubMed Web of Science ®Google Scholar
• Bowie A, O'Neill LA. Oxidative stress and nuclear factor-kappaB activation: A reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000; 59: 13–23
   PubMed Web of Science ®Google Scholar
• Cemerski S, van Meerwijk JP, Romagnoli P. Oxidative-stress-induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules. Eur J Immunol 2003; 33: 2178–2185
   PubMedGoogle Scholar
• Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G, Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 1994; 53: 51–53
   PubMed Web of Science ®Google Scholar
• Hagfors L, Leanderson P, Skoldstam L, Andersson J, Johansson G. Antioxodant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, mediterranean dietary intervention study on patients with rheumatoid arthritis. Nutr J 2000; 3: 2–5
   Google Scholar
• Salvemini D, Mazzon E, Dugo L, Serraino I, De Sarro A, Caputi AP, Cuzzocrea S. Amelioration of joint disease in a rat model of collagen-induced arthritis by M40403, a superoxide dismutase mimetic. Arthritis Rheum 2001; 44: 2909–2921
   PubMed Web of Science ®Google Scholar
• Maurice MM, Nakamura H, van der Voort EAM, van Vliet AI, Staal FJT, Tak PP, Breedveld FC, Verweij CL. Evidence for a role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol 1997; 158: 1458–1465
   PubMed Web of Science ®Google Scholar
• Maurice MM, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F, Lechner S, van der Voort EAM, Leow A, Versendaaal J, Muller-Ladner U, Yodoi J, Tak PP, Breedveld FC, Verweij CL. Expression of the thioredoxin–thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 1999; 42: 2430–2439
   PubMed Web of Science ®Google Scholar
• Yoshida S, Katoh T, Tessuka T, Uno K, Matsui N, Okamoto T. Involvement of thioredoxin in rheumatoid arthritis: Its costimulatory roles in the TNF-alpha induced production of IL-6 and IL-8 cultured synovial fibroblasts. J Immunol 1999; 163: 351–358
   PubMed Web of Science ®Google Scholar
• Jikimoto T, Nishiikubo Y, Koshiba M, Kanagawa S, Morinobu S, Morinobu A, Saura R, Mizuno K, Kondo S, Toyokuni S, Nakamura H, Yodoi J, Kumagai S. Thioredoxin as a biomarker for oxidative stress in patients with rheumatoid arthritis. Mol Immunol 2001; 38: 765–772
   Web of Science ®Google Scholar
• Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis. Clin Chim Acta 2006; 367: 156–161
   Google Scholar
• Holmgren A. Thioredoxin. Annu Rev Biochem 1985; 54: 237–271
   PubMed Web of Science ®Google Scholar
• Tanaka T, Nakamura H, Nishiyama A, Hosoi F, Masuta IH, Wada H, Yodoi J. Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging. Free Radic Res 2000; 33: 851–855
   PubMed Web of Science ®Google Scholar
• Powis G, Montfort WR. Properties and biological activities of thioredoxins. Annu Rev Pharmacol Toxicol 2001; 41: 261–295
   PubMed Web of Science ®Google Scholar
• Sun QA, Wu Y, Zappacosta F, Jeang KT, Lee BJ, Hatfield DL, Gladyshev VN. Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductase. J Biol Chem 1999; 274: 24522–24530
   PubMed Web of Science ®Google Scholar
• Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997; 272: 20313–20316
   PubMed Web of Science ®Google Scholar
• Levine RL. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 2002; 32: 790–796
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324
   PubMed Web of Science ®Google Scholar
• Hernvann A, Aussel C, Cynober L, Moatti N, Ekindjian OG. IL-1β, a strong mediator for glucose uptake by rheumatoid and non rheumatoid cultured human synoviocytes. FEBS Lett 1992; 303: 77–80
   Google Scholar
• Arner ES, Zhong L, Holmgren A. Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol 1999; 300: 226–239
   PubMed Web of Science ®Google Scholar
• Gasdaska PY, Gasdaska JR, Cochran S, Powis G. Cloning and sequencing of a human thioredoxin reductase. FEBS Lett 1995; 373: 5–9
   PubMed Web of Science ®Google Scholar
• Katoh M. Expression and regulation of WNT1 in human cancer: Up-regulation of WNT1 by beta-estradiol in MCF-7 cells. Int J Oncol 2002; 22: 209–212
   Google Scholar
• Reznick AZ, Packer L. Oxidative damage to proteins: Spectrophotometric method for carbonyl assay. Methods Enzymol 1994; 233: 357–363
   PubMed Web of Science ®Google Scholar
• Kim JR, Yoon HW, Kwon KS, Lee SR, Rhee SG. Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH. Anal Biochem 2000; 283: 214–221
   PubMed Web of Science ®Google Scholar
• Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971; 44: 276–287
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121–126
   PubMed Web of Science ®Google Scholar
• Baker MA, Cerniglia GJ, Zaman A. Microliter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 1990; 190: 360–365
   PubMed Web of Science ®Google Scholar
• Yamada KI, Nakamura T, Utsumi H. Enhanced intraarticular free radical reactions in adjuvant arthritis rats. Free Radic Res 2006; 40: 455–460
   PubMed Web of Science ®Google Scholar
• Bjornstedt M, Hamberq M, Kumar S, Xue J, Holmgren A. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH ans selenocystine strongly stimulates the reaction via catalytically generated selenols. J Biol Chem 1995; 270: 11761–11764
   PubMed Web of Science ®Google Scholar
• May JM, Mendiratta S, Hill KE, Burk RF. Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J Biol Chem 1997; 272: 22607–22610
   PubMed Web of Science ®Google Scholar
• Das KC, Lewis-Molock Y, White CW. Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am J Respir Cell Mol Biol 1997; 17: 713–726
   PubMed Web of Science ®Google Scholar
• Kim JR, Lee SM, Cho SH, Kim JH, Kim BH, Kwon J, Choi CY, Kim YD, Lee SR. Oxidation of thioredoxin reductase in Hela cells stimulated with tumor necrosis factor-alpha. FEBS Lett 2004; 567: 189–196
   PubMed Web of Science ®Google Scholar
• Park YS, Fujiwara N, Koh YH, Miyamoto Y, Suzuki K, Honke K, Taniquchi N. Induction of thioredoxin reductase gene expression by peroxynitrite in human umbilical vein endothelial cells. Biol Chem 2002; 383: 683–691
   Google Scholar
• Lee SR, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG. Mammalian thioredoxin reductase: Oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci USA 2000; 97: 2521–2526
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Fuji T, Fuji F, Taniquchi N. Roles of N-terminal active cysteines and C-terminal cysteine-selenocysteine in the catalytic mechanism of mammalian thioredoxin reductase. J Biochem (Tokyo) 2001; 129: 803–812
   PubMed Web of Science ®Google Scholar
• Gromer S, Wissing J, Behne D, Ashman K, Schirmer RH, Flohe L, Becker K. A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem J 1998; 332: 591–592
   PubMed Web of Science ®Google Scholar
• Gorlatov SN, Stadtman TC. Human thioredoxin reductase from Hela cells: Selective alkylation of the selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin. Proc Natl Acad Sci USA 1998; 95: 8520–8525
   PubMed Web of Science ®Google Scholar
• Fang J, Holmgren A. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo. J Am Chem Soc 2006; 128: 1879–1885
   PubMed Web of Science ®Google Scholar
• Jaswal S, Metha HC, Sood AK, Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 2003; 338: 123–129
   PubMed Web of Science ®Google Scholar
• Anestal K, Arner ES. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. J Biol Chem 2003; 278: 15966–15972
   PubMed Web of Science ®Google Scholar
• Li PF, Dietz R, von Harsdorf R. Reactive oxygen species induce apoptosis of vascular smooth muscle cells. FEBS Lett 1997; 404: 249–252
   PubMedGoogle Scholar
• Tsuji G, Koshiba M, Nakamura H, Kosada H, Hatachi S, Kurimoto C, Kurosada M, Hayashi Y, Yodoi J, Kumagai S. Thioredoxin protects against joint destruction in a murine arthritis model. Free Radic Biol Med 2006; 40: 1721–1731
   Google Scholar